Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods
Preprint
Abstract
Background Faecal microbiota transplantation (FMT) is a developing therapy for disorders related to gut dysbiosis. Despite its growing application, standardized protocols for FMT filtrate preparation and quality assessment remain undeveloped. The viability of bacteria in the filtrate is crucial for FMT’s efficacy and for validating protocol execution. We compared two methods—in vitro cultivation and membrane integrity assessment—for their accuracy, reproducibility, and clinical applicability in measuring bacterial viability in frozen FMT stool filtrate. Methods Bacterial viability in stool filtrate was evaluated using (i) membrane integrity through fluorescent DNA staining with SYTO9 and propidium iodide, followed by flow cytometry; and (ii) culturable bacteria counts (colony-forming units, CFU) under aerobic or anaerobic conditions. Results We refined the bacterial DNA staining protocol integrated with flow cytometry for stool samples. Both the membrane integrity-based and cultivation-based methods exhibited significant variability in bacterial viability across different FMT filtrates, without correlation. The cultivation-based method showed a mean coefficient of variance of 17%, ranging from 5.3% to 52.9%. Conversely, the membrane integrity approach yielded highly reproducible results, with a median coefficient of variance for viable cells of 0.9%, ranging from 8.5% to 0.04%. Conclusion Bacterial viability assessment using cultivation-dependent methods produces inconsistent outcomes. In contrast, the membrane integrity method offers robust and precise data, making it a viable option for routine faecal material evaluation in FMT.Keywords
All Related Versions
- Published version: Journal of Clinical Laboratory Analysis, 38 (19-20), e25105.
This publication has 39 references indexed in Scilit:
- Key determinants of success in fecal microbiota transplantation: From microbiome to clinicCell Host & Microbe, 2023
- Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitisIndian Journal of Gastroenterology, 2022
- The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantationGut Microbes, 2022
- The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide surveyThe Lancet Regional Health - Europe, 2021
- Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantationGut Microbes, 2020
- Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative ColitisGastroenterology, 2019
- Bacterial viability in faecal transplants: Which bacteria survive?EBioMedicine, 2019
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clinical Infectious Diseases, 2018
- Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile InfectionGastroenterology, 2017
- The Human Intestinal Microbiome in Health and DiseaseNew England Journal of Medicine, 2016